Suchergebnisse - "Tomita, Yusuke"

PubPharm (10)

1

Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia

enthalten in: Leukemia research | 2021

von Carraway, H. | Sawalha, Y. | Gojo, I. | +17

2

Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer

enthalten in: BJU international | 2021

von Madan, R. | Karzai, F. | Al Harthy, M. | +24

3

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma : an open-label, single-centre, phase 2 trial

enthalten in: The Lancet. Oncology | 2020

von Apolo, A. | Nadal, R. | Tomita, Y. | +29

CommentIn: Lancet Oncol. 2020 Aug;21(8):1005-1006. - PMID 32645283

4

Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2018

von Yuno, A. | Lee, M. | Lee, S. | +4

5

UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation

enthalten in: Journal of clinical pharmacology | 2016

von Peer, C. | Goey, A. | Sissung, T. | +8

6

Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer

enthalten in: Journal of clinical pharmacology | 2016

von Goey, A. | Sissung, T. | Peer, C. | +10

7

The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer : Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat

enthalten in: Oncoimmunology | 2016

von Tomita, Y. | Lee, M. | Lee, S. | +5

8

Immunotherapies for bladder cancer : a new hope

enthalten in: Current opinion in urology | 2015

von Fakhrejahani, F. | Tomita, Y. | Maj-Hes, A. | +3

9

Emerging immunotherapies for bladder cancer

enthalten in: Current opinion in oncology | 2015

von Kim, J. | Tomita, Y. | Trepel, J. | +1

10

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors : a clinical and translational study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Thomas, A. | Rajan, A. | Szabo, E. | +15

1
[1]